Fulcrum Therapeutics, Inc. (FULC) › Shares OutstandingFulcrum Therapeutics, Inc. (FULC) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 1.59M2019: 22.65M2020: 27.94M2021: 40.63M2022: 52.10M2023: 61.92M2024: 53.97M2025: 66.58M66.58M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202566.58M+23.4%202453.97M-12.8%202361.92M+18.8%202252.10M+28.2%202140.63M+45.4%202027.94M+23.3%201922.65M+1326.6%20181.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share